← Eichor
Study identifier: NCT05692011 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

AN69ST Verse PS in CBP in Septic Children

Condition: Sepsis  ·  Sponsor: Children's Hospital of Fudan University

PhaseN/A
Planned participants80
Who can joinAll sexes, 29 Days to 28 Years
Healthy volunteersNo

About this study

In septic shock, dysregulated host responses to pathogens lead to cytokine storms that damage host tissues and organs, further contributing to the development of organ dysfunction and increased mortality. For sepsis, blood purification can remove inflammatory factors in sepsis by filtration or adsorption, so as to achieve the purpose of reducing inflammatory mediators in the body. However, there are few prospective randomized controlled studies in children. Therefore, this study intends to compare the efficacy and prognosis of different membrane on children with sepsis through a perspective cohort study, so as to provide a corresponding basis for the treatment of children with sepsis blood purification.

This description comes directly from the study's public registry record.

Talk to the study team

Jiayun Ying  ·  18817583962  ·  jiayundoctor@163.com

Guoping Lu  ·  13788904150  ·  13788904150@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital of Fudan UniversityShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05692011